Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

NB-506 maintains activity against camptothecin-resistant human leukemia cells

April 24, 2001

Naja venom fraction induces apoptosis in human leukemia cells

April 23, 2001

Vical discontinues current Leuvectin trial in kidney cancer and plans new trial

April 23, 2001

Cotara enters additional trial for liver cancer

April 23, 2001

Patient dosing begins in phase I trial of intravenous IL-2 gene medicine

April 23, 2001

Urokinase inhibitors synthesized at Abbott; compositions and methods of use described

April 23, 2001

Topoisomerase I and II inhibitor conjugates jointly designed by U.S. universities

April 23, 2001

Gem Pharmaceuticals develops noncardiotoxic anthracycline antitumor agents

April 23, 2001

Japanese patent covers Yamanouchi's VEGF-inhibitory tricyclic heteroaryl compounds

April 20, 2001

Phase III trial of Metvix PDT indicates superiority to surgery in nodular BCC

April 20, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...